Aarti Drugs, 524348, AARTIDRUGS Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,183.04
20.48
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,757.03
0.29%
2.38

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

8.71
6.96
0.53

EBITDA CAGR (%)

10 Years
5 Years
3 Years

6.41
3.86
-0.72

PAT CAGR (%)

10 Years
5 Years
3 Years

8.30
3.93
-5.79

P:E (Median)

8 Years
5 Years
3 Years

21.89
23.98
24.87

P:BV (Average)

8 Years
5 Years
3 Years

3.99
4.71
3.63

EV:EBITDA (Average)

8 Years
5 Years
3 Years

13.04
15.42
15.27

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 18.65 17.1 27 34
P/E Ratio 24.42 26.63 16.87 13.4
Revenue 2267 2456 2870 3261
EBITDA 316 292 416 506
Net Income 171 156 247 311
ROA 6.5
P/B Ratio 3.27 3.03 2.67 2.31
ROE 13.86 11.8 16.8 18.5
FCFF 103.78
FCFF Yield 2.21

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 514.54 538.21 -4.40% 543.09 577.54 -5.96% 492.96 591.63 -16.68% 559.53 696.41 -19.66%
Expenses 454.29 478.47 -5.05% 483.55 512.12 -5.58% 438.74 519.72 -15.58% 490.47 607.89 -19.32%
EBITDA 60.25 59.74 0.85% 59.54 65.42 -8.99% 54.22 71.91 -24.60% 69.06 88.52 -21.98%
EBIDTM 11.71% 11.10% 10.96% 11.33% 11.00% 12.15% 12.34% 12.71%
Other Income 11.37 1.68 576.79% 0.38 0.74 -48.65% 0.11 0.65 -83.08% 1.11 0.93 19.35%
Interest 7.57 6.75 12.15% 7.17 7.55 -5.03% 7.46 7.77 -3.99% 8.09 8.35 -3.11%
Depreciation 12.02 11.80 1.86% 11.86 11.78 0.68% 11.71 11.75 -0.34% 12.34 11.68 5.65%
PBT 52.03 42.87 21.37% 40.89 46.83 -12.68% 35.16 53.04 -33.71% 49.74 69.42 -28.35%
Tax 13.50 11.25 20.00% 10.50 12.25 -14.29% 8.25 13.50 -38.89% 13.60 16.25 -16.31%
PAT 38.53 31.62 21.85% 30.39 34.58 -12.12% 26.91 39.54 -31.94% 36.14 53.17 -32.03%
PATM 7.49% 5.88% 5.60% 5.99% 5.46% 6.68% 6.46% 7.63%
EPS 4.22 3.46 21.97% 3.33 3.79 -12.14% 2.95 4.33 -31.87% 3.96 5.82 -31.96%

Description Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var%
Net Sales 556.60 605.94 -8.14% 598.33 641.54 -6.74% 555.34 661.11 -16.00% 619.99 742.41 -16.49%
Expenses 494.87 535.80 -7.64% 531.28 565.09 -5.98% 490.38 577.04 -15.02% 534.18 648.87 -17.68%
EBITDA 61.73 70.14 -11.99% 67.05 76.45 -12.30% 64.96 84.07 -22.73% 85.81 93.54 -8.26%
EBIDTM 11.09% 11.58% 11.21% 11.92% 11.70% 12.72% 13.84% 12.60%
Other Income 11.90 1.67 612.57% 1.48 0.68 117.65% 1.11 0.60 85.00% 1.08 0.87 24.14%
Interest 9.07 7.60 19.34% 8.93 8.25 8.24% 8.71 8.54 1.99% 9.13 8.63 5.79%
Depreciation 13.80 12.66 9.00% 13.72 12.61 8.80% 13.38 12.60 6.19% 13.58 12.50 8.64%
PBT 50.76 51.55 -1.53% 45.88 56.27 -18.46% 43.98 63.53 -30.77% 64.18 73.28 -12.42%
Tax 13.67 14.84 -7.88% 10.92 16.67 -34.49% 10.71 15.56 -31.17% 16.87 17.10 -1.35%
PAT 37.09 36.71 1.04% 34.96 39.60 -11.72% 33.27 47.97 -30.64% 47.31 56.18 -15.79%
PATM 6.66% 6.06% 5.84% 6.17% 5.99% 7.26% 7.63% 7.57%
EPS 4.06 3.99 1.75% 3.84 4.31 -10.90% 3.62 5.17 -29.98% 5.15 6.06 -15.02%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 2,110.12 2,266.91 2,497.97 2,251.17 1,914.89 1,634.92 1,454.25 1,140.46 1,088.72 1,075.50 1,087.22 Net Sales Growth -12.22% -9.25% 10.96% 17.56% 17.12% 12.42% 27.51% 4.75% 1.23% -1.08% Cost Of Goods Sold 1,389.56 1,479.38 1,690.45 1,456.26 1,122.09 1,028.03 950.77 686.64 673.19 690.90 717.77 Gross Profit 720.56 787.53 807.52 794.92 792.80 606.89 503.48 453.82 415.53 384.59 369.45 GP Margin 34.15% 34.74% 32.33% 35.31% 41.40% 37.12% 34.62% 39.79% 38.17% 35.76% 33.98% Total Expenditure 1,867.05 1,997.74 2,211.92 1,930.01 1,510.52 1,386.98 1,251.51 955.32 909.74 899.74 914.93 Power & Fuel Cost - 151.64 153.45 126.05 95.64 101.04 82.14 68.97 56.61 52.64 49.30 % Of Sales - 6.69% 6.14% 5.60% 4.99% 6.18% 5.65% 6.05% 5.20% 4.89% 4.53% Employee Cost - 70.20 64.30 57.17 55.60 52.65 47.23 45.12 42.76 36.93 32.68 % Of Sales - 3.10% 2.57% 2.54% 2.90% 3.22% 3.25% 3.96% 3.93% 3.43% 3.01% Manufacturing Exp. - 213.77 207.43 194.14 155.21 139.77 121.08 108.53 90.77 77.25 73.58 % Of Sales - 9.43% 8.30% 8.62% 8.11% 8.55% 8.33% 9.52% 8.34% 7.18% 6.77% General & Admin Exp. - 24.28 22.94 25.46 25.58 18.53 12.51 10.79 10.39 9.85 10.21 % Of Sales - 1.07% 0.92% 1.13% 1.34% 1.13% 0.86% 0.95% 0.95% 0.92% 0.94% Selling & Distn. Exp. - 50.95 67.67 65.68 52.73 41.55 34.95 31.58 30.35 27.78 28.95 % Of Sales - 2.25% 2.71% 2.92% 2.75% 2.54% 2.40% 2.77% 2.79% 2.58% 2.66% Miscellaneous Exp. - 7.52 5.68 5.24 3.67 5.40 2.83 3.69 5.67 4.38 28.95 % Of Sales - 0.33% 0.23% 0.23% 0.19% 0.33% 0.19% 0.32% 0.52% 0.41% 0.22% EBITDA 243.07 269.17 286.05 321.16 404.37 247.94 202.74 185.14 178.98 175.76 172.29 EBITDA Margin 11.52% 11.87% 11.45% 14.27% 21.12% 15.17% 13.94% 16.23% 16.44% 16.34% 15.85% Other Income 12.97 4.18 2.23 4.77 6.42 1.06 2.51 1.17 3.53 0.00 0.65 Interest 30.29 33.21 36.18 23.05 25.71 35.74 41.00 36.30 38.05 47.34 42.21 Depreciation 47.93 47.67 47.29 47.39 47.60 46.67 40.39 37.80 36.69 35.58 30.66 PBT 177.82 192.48 204.81 255.50 337.49 166.60 123.86 112.21 107.78 92.84 100.06 Tax 45.85 50.60 52.00 60.50 80.00 39.30 40.37 38.80 32.30 26.55 22.47 Tax Rate 25.78% 26.29% 25.39% 23.68% 23.69% 22.46% 31.63% 34.58% 29.97% 28.60% 22.46% PAT 131.97 141.88 152.81 195.00 257.71 135.67 87.26 73.41 75.48 66.29 77.60 PAT before Minority Interest 131.97 141.88 152.81 195.00 257.71 135.67 87.26 73.41 75.48 66.29 77.60 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.25% 6.26% 6.12% 8.66% 13.46% 8.30% 6.00% 6.44% 6.93% 6.16% 7.14% PAT Growth -16.95% -7.15% -21.64% -24.33% 89.95% 55.48% 18.87% -2.74% 13.86% -14.57% EPS 14.45 15.54 16.74 21.36 28.23 14.86 9.56 8.04 8.27 7.26 8.50

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 2,330.26 2,528.58 2,716.05 2,488.65 2,154.78 1,806.09 1,560.94 1,243.63 1,195.17 1,139.84 1,096.88 Net Sales Growth -12.10% -6.90% 9.14% 15.49% 19.31% 15.71% 25.51% 4.05% 4.85% 3.92% Cost Of Goods Sold 1,502.31 1,605.15 1,813.56 1,614.49 1,263.35 1,127.29 1,013.53 737.72 744.43 735.08 724.24 Gross Profit 827.95 923.42 902.50 874.15 891.43 678.79 547.40 505.91 450.75 404.77 372.65 GP Margin 35.53% 36.52% 33.23% 35.13% 41.37% 37.58% 35.07% 40.68% 37.71% 35.51% 33.97% Total Expenditure 2,050.71 2,207.74 2,406.60 2,156.05 1,714.40 1,540.57 1,350.03 1,041.76 1,004.68 960.02 924.51 Power & Fuel Cost - 154.31 156.10 128.34 98.20 103.83 84.39 71.42 59.42 53.93 49.56 % Of Sales - 6.10% 5.75% 5.16% 4.56% 5.75% 5.41% 5.74% 4.97% 4.73% 4.52% Employee Cost - 90.60 80.43 69.30 65.88 61.35 54.55 52.14 47.95 40.19 33.26 % Of Sales - 3.58% 2.96% 2.78% 3.06% 3.40% 3.49% 4.19% 4.01% 3.53% 3.03% Manufacturing Exp. - 252.91 241.58 230.56 181.41 160.38 142.69 130.01 103.21 87.60 75.53 % Of Sales - 10.00% 8.89% 9.26% 8.42% 8.88% 9.14% 10.45% 8.64% 7.69% 6.89% General & Admin Exp. - 29.50 28.79 30.42 29.03 21.39 14.24 12.22 12.81 10.98 10.48 % Of Sales - 1.17% 1.06% 1.22% 1.35% 1.18% 0.91% 0.98% 1.07% 0.96% 0.96% Selling & Distn. Exp. - 63.79 75.54 73.99 70.99 59.46 37.51 34.00 31.16 27.82 28.99 % Of Sales - 2.52% 2.78% 2.97% 3.29% 3.29% 2.40% 2.73% 2.61% 2.44% 2.64% Miscellaneous Exp. - 11.48 10.61 8.95 5.54 6.88 3.11 4.24 5.71 4.42 28.99 % Of Sales - 0.45% 0.39% 0.36% 0.26% 0.38% 0.20% 0.34% 0.48% 0.39% 0.22% EBITDA 279.55 320.84 309.45 332.60 440.38 265.52 210.91 201.87 190.49 179.82 172.37 EBITDA Margin 12.00% 12.69% 11.39% 13.36% 20.44% 14.70% 13.51% 16.23% 15.94% 15.78% 15.71% Other Income 15.57 4.03 2.19 11.32 4.53 1.48 2.41 1.05 4.00 0.00 0.65 Interest 35.84 37.89 37.14 23.91 26.23 37.42 43.51 38.36 40.02 48.02 42.28 Depreciation 54.48 51.45 50.32 50.05 49.88 48.75 42.56 40.06 38.46 36.53 31.02 PBT 204.80 235.53 224.18 269.96 368.79 180.82 127.26 124.50 116.01 95.27 99.72 Tax 52.17 63.94 57.82 64.96 88.62 43.89 41.27 42.20 34.21 26.55 22.47 Tax Rate 25.47% 27.15% 25.79% 24.06% 24.02% 23.69% 31.50% 33.90% 29.49% 27.87% 22.53% PAT 152.63 171.42 166.31 205.04 280.41 141.40 89.75 82.31 81.80 68.72 77.25 PAT before Minority Interest 152.66 171.59 166.36 205.00 280.40 141.40 89.75 82.31 81.80 68.72 77.25 Minority Interest 0.03 -0.17 -0.05 0.04 0.01 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 6.55% 6.78% 6.12% 8.24% 13.01% 7.83% 5.75% 6.62% 6.84% 6.03% 7.04% PAT Growth -15.42% 3.07% -18.89% -26.88% 98.31% 57.55% 9.04% 0.62% 19.03% -11.04% EPS 16.72 18.78 18.22 22.46 30.71 15.49 9.83 9.02 8.96 7.53 8.46

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,175.21 1,114.30 972.17 859.61 621.79 518.58 433.17 386.97 350.31 303.70 Share Capital 91.94 92.60 92.60 93.20 23.30 23.58 23.58 23.86 24.22 24.22 Total Reserves 1,083.27 1,021.70 879.57 766.41 598.49 494.99 409.59 363.11 326.10 279.49 Non-Current Liabilities 311.81 233.80 207.67 255.50 294.42 307.00 294.33 279.97 227.31 198.83 Secured Loans 234.69 153.32 109.76 138.99 167.71 186.69 173.99 173.28 160.64 140.72 Unsecured Loans 3.57 8.57 8.57 8.57 8.57 8.57 12.17 14.17 14.57 10.75 Long Term Provisions 2.74 2.98 7.86 22.12 25.12 12.80 16.87 8.66 1.42 0.29 Current Liabilities 684.60 847.39 854.68 521.89 554.49 547.36 588.74 449.18 477.08 464.40 Trade Payables 393.29 419.01 416.19 293.04 316.37 228.43 239.67 170.30 164.18 150.19 Other Current Liabilities 113.80 89.20 82.85 85.40 81.36 71.15 51.94 47.63 42.24 41.19 Short Term Borrowings 173.47 332.42 353.05 142.18 154.61 246.34 296.24 229.57 257.37 251.27 Short Term Provisions 4.03 6.76 2.59 1.28 2.14 1.43 0.89 1.68 13.28 21.76 Total Liabilities 2,171.62 2,195.49 2,034.52 1,637.00 1,470.70 1,372.94 1,316.24 1,116.12 1,054.70 966.93 Net Block 722.29 634.48 649.41 630.52 611.57 585.67 563.59 542.32 462.77 431.48 Gross Block 1,276.97 1,141.49 1,112.42 1,052.68 987.49 920.74 862.31 803.53 690.74 665.09 Accumulated Depreciation 554.67 507.00 463.01 422.16 375.92 335.07 298.72 261.21 227.97 233.61 Non Current Assets 990.60 845.96 761.33 676.88 645.33 637.93 619.59 586.64 512.67 460.19 Capital Work in Progress 221.62 160.75 59.62 15.95 10.96 32.37 27.99 14.13 34.04 13.35 Non Current Investment 29.97 28.62 28.03 24.32 20.38 18.92 17.24 18.42 11.12 11.11 Long Term Loans & Adv. 16.71 22.11 24.26 6.09 2.42 0.97 10.77 11.76 4.74 4.24 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,181.02 1,349.53 1,273.19 960.13 825.36 735.00 696.65 529.48 542.03 506.74 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 441.77 477.73 488.46 390.38 307.41 227.71 254.10 188.75 167.05 153.36 Sundry Debtors 643.95 801.68 711.64 503.99 464.34 436.90 365.23 278.27 321.19 307.59 Cash & Bank 3.82 2.68 2.21 3.81 3.85 4.85 3.91 4.00 4.50 3.43 Other Current Assets 91.48 2.62 0.70 2.44 49.77 65.56 73.40 58.45 49.28 42.36 Short Term Loans & Adv. 88.67 64.83 70.18 59.52 47.50 59.00 63.19 58.45 49.28 42.36 Net Current Assets 496.42 502.14 418.52 438.23 270.88 187.65 107.92 80.30 64.95 42.34 Total Assets 2,171.62 2,195.49 2,034.52 1,637.01 1,470.69 1,372.93 1,316.24 1,116.12 1,054.70 966.93

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,281.55 1,192.43 1,036.36 913.42 652.49 543.45 455.43 400.13 357.40 308.15 Share Capital 91.94 92.60 92.60 93.20 23.30 23.58 23.58 23.86 24.22 24.22 Total Reserves 1,189.61 1,099.83 943.76 820.22 629.19 519.86 431.85 376.27 333.18 283.94 Non-Current Liabilities 354.86 279.25 231.60 257.25 300.82 321.06 312.31 296.59 243.78 211.03 Secured Loans 271.76 196.11 129.93 138.99 171.74 199.64 190.53 187.38 176.66 152.72 Unsecured Loans 3.57 8.57 8.57 8.57 8.57 8.57 12.17 14.17 14.57 10.75 Long Term Provisions 2.74 3.03 9.23 21.67 25.13 12.32 16.87 8.39 1.42 0.29 Current Liabilities 795.54 949.48 940.06 595.36 623.19 590.98 621.68 494.31 501.02 482.76 Trade Payables 425.49 480.27 468.67 329.97 329.55 242.63 258.73 196.97 184.90 166.72 Other Current Liabilities 151.21 100.07 111.33 105.38 132.83 82.94 56.42 51.00 43.80 41.53 Short Term Borrowings 214.70 360.55 356.34 157.21 157.73 263.25 305.64 244.66 258.41 252.43 Short Term Provisions 4.13 8.60 3.71 2.80 3.08 2.16 0.89 1.68 13.91 22.08 Total Liabilities 2,432.36 2,421.39 2,207.96 1,766.01 1,576.50 1,455.49 1,389.42 1,191.03 1,102.20 1,001.94 Net Block 811.09 676.23 689.93 665.40 643.81 624.86 602.39 581.09 493.42 448.46 Gross Block 1,388.16 1,202.18 1,169.00 1,101.02 1,030.97 970.09 909.20 848.13 725.47 685.21 Accumulated Depreciation 577.07 525.96 479.06 435.62 387.16 345.22 306.81 267.04 232.05 236.75 Non Current Assets 1,111.64 929.61 814.59 709.22 672.50 671.20 652.55 619.61 536.97 476.40 Capital Work in Progress 260.87 210.35 76.74 19.26 12.21 32.75 28.45 14.28 34.04 16.06 Non Current Investment 19.97 18.80 19.48 17.30 13.36 12.44 10.76 11.94 4.63 4.63 Long Term Loans & Adv. 19.70 24.23 28.44 7.26 3.12 1.15 10.95 12.30 4.88 7.24 Other Non Current Assets 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Current Assets 1,320.72 1,491.79 1,393.37 1,056.80 904.00 784.29 736.86 571.42 565.23 525.54 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 485.89 516.29 525.94 415.00 325.40 246.61 278.21 209.63 178.35 164.20 Sundry Debtors 704.55 864.84 749.90 555.23 488.63 458.54 374.94 296.81 331.69 314.27 Cash & Bank 9.43 8.96 22.33 9.78 7.64 5.55 4.27 4.17 4.82 3.58 Other Current Assets 120.84 3.04 0.70 2.44 82.32 73.58 79.44 60.81 50.37 43.49 Short Term Loans & Adv. 117.61 98.66 94.50 74.35 75.50 67.02 69.23 60.81 50.37 43.49 Net Current Assets 525.18 542.31 453.31 461.44 280.81 193.31 115.19 77.11 64.20 42.78 Total Assets 2,432.36 2,421.40 2,207.96 1,766.02 1,576.50 1,455.49 1,389.41 1,191.03 1,102.20 1,001.94

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 337.10 161.70 39.90 154.18 196.15 147.30 61.93 174.41 125.27 106.83 PBT 192.48 204.81 255.50 337.71 174.97 127.62 112.21 107.78 92.84 100.06 Adjustment 77.69 78.43 66.76 65.35 79.82 70.77 71.06 68.20 78.20 68.73 Changes in Working Capital 118.17 -66.71 -202.27 -161.11 -21.34 -22.19 -99.42 17.93 -25.75 -47.03 Cash after chg. in Working capital 388.34 216.53 119.99 241.95 233.46 176.21 83.85 193.91 145.29 121.77 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -51.23 -54.83 -80.09 -87.78 -37.32 -28.91 -21.92 -19.51 -20.02 -14.94 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -187.09 -131.14 -125.36 -69.03 -29.35 -59.33 -71.09 -96.29 -87.40 -102.30 Net Fixed Assets -196.35 -130.20 -103.41 -70.18 -45.34 -62.81 -72.64 -92.88 -46.34 -88.99 Net Investments -1.35 -0.59 -3.71 -3.94 -1.46 -1.68 1.18 -7.30 -0.01 -6.49 Others 10.61 -0.35 -18.24 5.09 17.45 5.16 0.37 3.89 -41.05 -6.82 Cash from Financing Activity -148.81 -30.54 84.11 -85.28 -167.76 -86.96 9.12 -78.42 -36.79 -5.49 Net Cash Inflow / Outflow 1.20 0.03 -1.35 -0.13 -0.96 1.01 -0.04 -0.31 1.07 -0.97 Opening Cash & Equivalents 1.52 1.49 2.84 2.98 3.94 2.93 2.97 3.28 3.43 4.40 Closing Cash & Equivalent 2.72 1.52 1.49 2.84 2.98 3.94 2.93 2.97 4.50 3.43

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 358.92 133.32 70.41 154.95 250.74 143.09 69.77 174.75 133.29 104.59 PBT 235.53 224.18 269.96 369.01 185.29 131.02 124.50 116.01 95.27 99.72 Adjustment 83.01 85.15 71.19 68.60 86.84 75.20 75.12 71.63 79.30 69.40 Changes in Working Capital 102.78 -116.34 -187.35 -185.99 19.49 -33.49 -105.19 8.47 -21.25 -49.58 Cash after chg. in Working capital 421.32 193.00 153.79 251.63 291.62 172.74 94.44 196.11 153.33 119.53 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -62.40 -59.67 -83.38 -96.68 -40.88 -29.64 -24.67 -21.36 -20.03 -14.94 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -223.65 -163.97 -149.64 -71.78 -33.21 -61.67 -73.54 -106.98 -98.79 -107.01 Net Fixed Assets -196.35 -130.20 -103.41 -70.18 -45.34 -62.81 -72.64 -92.88 -46.34 -322.27 Net Investments -1.35 -0.59 -3.71 -3.94 -1.46 -1.68 1.18 -7.30 -0.01 13.50 Others -25.95 -33.18 -42.52 2.34 13.59 2.82 -2.08 -6.80 -52.44 201.76 Cash from Financing Activity -136.03 16.54 92.03 -81.13 -215.41 -80.07 3.92 -68.23 -33.26 1.46 Net Cash Inflow / Outflow -0.76 -14.11 12.80 2.04 2.13 1.35 0.15 -0.45 1.24 -0.95 Opening Cash & Equivalents 7.50 21.61 8.81 6.77 4.64 3.29 3.15 3.60 3.58 4.53 Closing Cash & Equivalent 6.74 7.50 21.61 8.81 6.77 4.64 3.29 3.15 4.82 3.58

Financial Ratios

Consolidated /

Standalone

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 127.83 120.34 104.99 92.23 66.72 54.98 45.92 40.55 36.16 31.35 ROA 6.50% 7.23% 10.62% 16.59% 9.54% 6.49% 6.04% 6.95% 6.56% 8.54% ROE 12.39% 14.65% 21.29% 34.79% 23.79% 18.34% 17.90% 20.47% 20.27% 27.98% ROCE 13.70% 15.38% 20.82% 33.35% 21.29% 17.39% 16.64% 18.03% 18.43% 20.80% Fixed Asset Turnover 1.87 2.22 2.08 1.88 1.71 1.63 1.39 1.59 1.73 1.88 Receivable days 116.38 110.56 98.55 92.29 100.60 100.66 101.27 92.25 98.01 90.90 Inventory Days 74.02 70.59 71.25 66.50 59.73 60.46 69.69 54.75 49.94 43.59 Payable days 100.21 90.17 88.88 99.12 67.96 68.73 71.92 65.41 62.49 57.39 Cash Conversion Cycle 90.20 90.98 80.91 59.67 92.38 92.40 99.04 81.59 85.46 77.10 Total Debt/Equity 0.40 0.48 0.53 0.38 0.59 0.91 1.19 1.16 1.23 1.43 Interest Cover 6.80 6.66 12.08 14.13 5.90 4.11 4.09 3.83 2.96 3.37

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 139.40 128.77 111.92 98.01 70.01 57.61 48.28 41.93 36.90 31.81 ROA 7.07% 7.19% 10.32% 16.78% 9.33% 6.31% 6.38% 7.13% 6.53% 10.13% ROE 13.87% 14.93% 21.03% 35.81% 23.65% 17.97% 19.24% 21.60% 20.65% 32.78% ROCE 15.01% 15.49% 20.75% 34.52% 21.39% 17.01% 17.31% 18.50% 18.33% 23.93% Fixed Asset Turnover 1.95 2.29 2.19 2.02 1.81 1.66 1.44 1.64 1.75 2.19 Receivable days 113.27 108.50 95.71 88.41 95.71 97.45 97.10 89.05 95.59 67.25 Inventory Days 72.33 70.03 69.00 62.71 57.80 61.36 70.52 54.97 50.69 39.52 Payable days 102.98 95.49 90.28 95.27 64.68 68.08 73.82 67.66 65.68 45.51 Cash Conversion Cycle 82.62 83.04 74.43 55.85 88.83 90.73 93.79 76.36 80.60 61.26 Total Debt/Equity 0.44 0.51 0.52 0.38 0.58 0.93 1.20 1.20 1.26 1.45 Interest Cover 7.22 7.04 12.29 15.07 5.95 4.01 4.25 3.90 2.98 3.36

Top Investors:

dsp small cap fund

harit pragji shah

jayshree harit shah

icici prudential pharma healthcare and diaganostics (p.h.d) fund

investor education and protection fund (iepf)

llp

Annual Reports:

News Update:

Aarti Drugs gets nod to invest Rs 25 crore in Pinnacle Life Science
30th Jan 2025, 09:38 AM

The Board of Directors of the company at its meeting held on January 29, 2025, approved the same
Read More
Aarti Drugs - Quarterly Results
29th Jan 2025, 16:41 PM

Read More
Aarti Drugs inks pact to acquire 26.25% stake in Pro-Zeal Green Power Six
10th Jan 2025, 09:58 AM

Cost of acquisition is Rs 1.65 crore
Read More

Aarti Drugs Ltd.

Pharmaceuticals & Drugs - API

BSE: 524348 | NSE: AARTIDRUGS

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update:

Aarti Drugs Ltd.

Pharmaceuticals & Drugs - API

BSE: 524348 | NSE: AARTIDRUGS

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Earnings Forecasts:

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Consolidated Figures in Rs. Crores /

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Cash Flow

Consolidated Figures in Rs. Crores /

Financial Ratios

Consolidated /

Top Investors:

Annual Reports:

News Update: